The association between alcoholic liver disease (ALD) and tumor necrosis factor-a gene (TNFA) polymorphisms has been analyzed in several studies, but results have been conflicting. The main purpose of this study was to integrate previous findings and explore whether these polymorphisms are associated with susceptibility to ALD. The authors surveyed studies on the relation between TNFA gene polymorphisms and ALD by means of an electronic database search. A meta-analysis was conducted in a random-effects model. The association between ALD and the À238G>A or À308G>A polymorphism of the TNFA gene has been analyzed in 11 studies. Concerning the À238G>A polymorphism, the authors found a significant association between possession of the A allele and risk of alcoholic liver cirrhosis (odds ratio ¼ 1.47, 95% confidence interval: 1.05, 2.07). Meta-analysis of the relation between the À308G>A polymorphism and ALD did not show any significant association. Given the limited number of studies and the potential biases, more data are needed to confirm the association described for the À238A allele.
ALD, and the potential relation between genetic polymorphisms and this disease has been extensively investigated (6, 7) . At first, genetic association studies focused mostly on alcohol-metabolizing enzyme genes, such as alcohol dehydrogenase (ADH), aldehyde dehydrogenase (ALDH), and, to a lesser extent, cytochrome P 450 2E1 (CYP2E1). Although the contradictory results obtained and the heterogeneous designs of these studies make it difficult to reach definite conclusions, 2 meta-analyses have shown that there are no clear associations between ADH2, ADH3, ALDH2, or CYP2E1 polymorphisms and the risk of ALD (8, 9) .
Among proinflammatory cytokines, TNF-a plays a key role in the pathogenesis of ALD (10) (11) (12) , and in 1 study, mice deficient in TNF-a type I receptor did not develop liver injury after long-term ethanol feeding (13) . Consequently, the TNFA gene is one of the potential candidate genes currently related to ALD susceptibility. In line with this, a study by Grove et al. (14) was the first showing that possession of the A allele of the TNFA À238G>A polymorphism conferred a higher risk of developing ALD. However, although Pastor et al. (15) also demonstrated an association between this allele and the risk of alcoholic liver cirrhosis, other studies have not replicated these findings (16, 17) . In addition, it has been suggested that this polymorphism could be associated with alcoholism itself (12) . Regarding the TNFA À308G>A polymorphism, only 1 study has found a significant association with ALD, specifically with alcoholic hepatitis (18) .
Our purpose in the current work was to clarify the potential relation between TNFA genetic polymorphisms and ALD by means of a Human Genome Epidemiology review including a meta-analysis of previous data.
MATERIALS AND METHODS

Inclusion criteria
For our analysis of the relation between TNFA polymorphisms and ALD, case-control studies that analyzed the distribution of these polymorphisms among patients with ALD and control subjects were considered eligible for inclusion. We considered as cases alcoholic patients with a histologic diagnosis of alcoholic liver cirrhosis or alcoholic hepatitis, as well as alcoholic subjects with alcoholic liver cirrhosis diagnosed by unequivocal clinical, ultrasonographic, or gastroscopic findings. Controls were considered either alcoholics without ALD or healthy subjects without liver disease.
For performing a secondary meta-analysis to analyze the relation between TNFA genetic polymorphisms and alcoholism, case-control studies that analyzed the distributions of these polymorphisms in alcoholics (cases) and healthy subjects (controls) were considered eligible for inclusion. The presence of alcoholism was defined according to standard criteria (such as the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, or the International Classification of Diseases, Tenth Revision), a history of alcohol consumption higher than 80 g/day for at least 10 years, or alcoholic end-organ damage.
Search strategy
We conducted an electronic search of the PubMed/ MEDLINE (National Library of Medicine) and EMBASE (Excerpta Medica) databases in order to identify observational studies published before June 2009 that had evaluated the relation between TNFA polymorphisms and ALD. The PubMed/MEDLINE database was searched using the following terms: (alcohol or alcoholism or alcoholic liver disease) and (polymorphism or genetic variant) and (tumor necrosis factor). EMBASE searches were executed using the Ovid search engine, with the following strategy: (alcoholism.de,ti. or alcoholic liver disease.ti or alcohol liver disease.de. or alcohol.ae,ti) and (DNA polymorphism.de. or genetic polymorphism.de. or polymorphism.ti.) or (tumor necrosis factor.ti,de.) We also retrieved additional studies by surveying the references of original research reports and review articles and by using the MEDLINE option ''Related Articles.'' Search results were limited to articles published in English and studies carried out in human subjects.
Extraction of data
The following information was extracted from the published article for each study: author's name, year of publication, ethnicity, location, age, male:female ratio, disease duration, use of age and sex matching, and consistency of genotype frequencies with Hardy-Weinberg equilibrium (HWE). The quality of each study selected for inclusion in the meta-analysis was assessed by analyzing the following relevant methodological aspects: representativeness of cases and controls; ascertainment of disease in cases and of absence of disease in controls; the use of blind genotyping; reporting of HWE testing; and adjustment for confounders.
Genotyped persons were categorized into the following groups if clinical data were available with which to do so: alcoholics with ALD, alcoholics without ALD, and healthy controls. In addition, alcoholics with liver disease were further classified according to the type of ALD. Allele and genotype frequencies were extracted or calculated from raw data. The bibliographic search and data extraction were carried out independently with results being entered into separate databases by 2 authors, and disagreements were resolved by consensus for all data.
Statistical analysis
In the main meta-analysis, we compared alcoholics with ALD (considered cases) with alcoholics without ALD (considered controls). We conducted another meta-analysis comparing alcoholics with ALD (cases) with healthy subjects (controls). Separate meta-analyses for the comparison of patients with specific types of ALD with controls and for the comparison of alcoholics defined by strict criteria with healthy controls were also performed. Meta-analyses were not performed when there were fewer than 4 studies, given the low sample size. For each allele of interest, the recessive contrast (assuming an effect only if the 2 alleles were present) and the dominant contrast (assuming an effect if either 1 or 2 alleles were present) were analyzed, since the genetic model for the analyzed polymorphisms was not known in advance (19) . Odds ratios and 95% confidence intervals were estimated for each study. Pooled odds ratios were calculated using a random-effects model. A P value less than 0.05 was considered statistically significant. Cochran's Q statistic was used to assess heterogeneity; a significant Q statistic (P < 0.10) indicated heterogeneity across studies. The I 2 statistic, representing the percentage of the observed between-study variability due to heterogeneity rather than to chance, was used for estimation of inconsistency in meta-analyses. The following suggested cutoff points were used: I 2 ¼ 0%-25%, no heterogeneity; I 2 ¼ 25%-50%, moderate heterogeneity; I 2 ¼ 50%-75%, large heterogeneity; and I 2 ¼ 75%-100%, extreme heterogeneity) (20) . HWE was tested by means of a v 2 test. We performed a sensitivity analysis examining the effect of excluding individual studies, as well as the effect of excluding studies in which the controls deviated significantly (P < 0.05) from HWE (21, 22) . The meta-analysis was carried out using the computer software packages RevMan 4.0 (23) and MIX (24, 25) .
RESULTS
Studies selected
Our search identified 14 articles reporting studies that met the search criteria. In 12 of the articles (11, 12, (14) (15) (16) (17) (18) (26) (27) (28) (29) (30) , investigators had analyzed the À238G>A polymorphism of TNFA (rs361525), and in 10 articles (11, 12, 14, 15, 17, 18, (26) (27) (28) 31) investigators had analyzed the À308G>A polymorphism (rs1800629). Other TNFA polymorphisms analyzed were À863C>A (rs1800630) in 3 articles (11, 12, 18) , À376G>A (rs1800750) in 2 articles (17, 27) , and À857C>T (rs1799724) in 1 article (11) . The relation between polymorphic TNFA microsatellites and ALD was evaluated in 2 articles (17, 32) , and in 1 article investigators analyzed the potential influence of the TNF receptor 2 polymorphism (29) .
In order to integrate the findings by means of a metaanalysis, we selected studies that had analyzed either the À238G>A polymorphism or the À308G>A polymorphism (from a total of 14 articles); the rest of the polymorphisms were not further evaluated, given the low number of studies found. The article published by Machado et al. (29) and the article published by Martins et al. (16) were considered to represent a single study, since the papers had overlapping subjects. In addition, Gonzalez-Quintela et al. (11) had focused on investigating the relation of serum TNF-a levels to alcohol consumption and TNFA polymorphisms; therefore, that study could not be included in our meta-analysis because of the lack of genotype data from a control group (either alcoholics without ALD or healthy controls).
Thus, a total of 11 studies were finally included in the meta-analysis. The characteristics of the genotyped groups and the genotype or allele frequencies for these studies are detailed in Tables 1 and 2 .
All studies had as exclusion criteria the presence of hepatitis B or C virus infection, and in 5 studies investigators also excluded subjects with other liver diseases (mostly autoimmune liver disease) (12, 14, 16, 18, 28, 31) . In 3 studies, the researchers reported matching subjects by age and Genotyping was performed in a different number of subjects for each polymorphism because of differences in DNA availability.
c Genotyping was performed in a different number of subjects for each polymorphism. sex (14, 15, 18) . All of these 11 studies were performed in Caucasians. Information regarding duration of ALD was not collected, since this information was not provided in any study. Genotyping methods used were polymerase chain reaction and restriction of the reaction product with the enzyme corresponding to each polymorphism, with the exception of the use of dot-blot hybridization instead of restriction enzymes in 2 studies (17, 31) . In 5 articles, investigators reported consecutively selecting cases with a clearly defined time frame (12, 14, 27, 28, 30) , and in 1 study controls were reported to have been selected in the same way (12) . Blind genotyping was reported for only 2 studies (18, 30) , the same number of studies in which adjustment for confounders was carried out (16, 30) . The control group was reported to have been tested for HWE in 4 studies (12, 14, 28, 30 ); HWE was not tested in any group in the rest of studies. Statistically significant deviations from HWE in the control group were found in 3 studies regarding the À308G>A polymorphism (18, 26, 31) and in 1 study regarding the À238G>A polymorphism (17) .
TNFA 2238G >A polymorphism and ALD Meta-analysis results for the association between the TNFA À238G>A polymorphism and the risk of ALD are shown in Figure 1 . A significant association was found between possession of the A allele (AA and AG genotypes combined) and the risk of alcoholic liver cirrhosis (odds ratio ¼ 1.47, 95% confidence interval: 1.05, 2.07; P ¼ 0.03) when patients with alcoholic liver cirrhosis were compared with healthy controls (Figure 1, third section) . In sensitivity analysis, exclusion of the study with controls deviating significantly from HWE (17) showed a significant association as well (odds ratio ¼ 1.69, 95% confidence interval: 1.07, 2.66; P ¼ 0.02). The exclusion of individual studies did not change this significant result either, except for exclusion of the study by Pastor et al. (15) , which produced a nonsignificant association. There were no significant associations of the A allele with ALD when patients with ALD were compared with alcoholics without ALD or healthy controls (Figure 1, first and second sections) . Taking into account the low number of subjects with the AA genotype, only a comparison of the combined AA and GA genotypes with the GG genotype was performed (dominant contrast for A allele). We did not perform a meta-analysis for the risk of alcoholic hepatitis or alcoholic liver cirrhosis comparing patients with alcoholic liver cirrhosis with alcoholics without ALD, because only 3 studies provided data for these comparisons. no significant associations of the A allele (AA and AG genotypes combined) with ALD or alcoholic liver cirrhosis. Significant heterogeneity (Q statistic P ¼ 0.06; I 2 ¼ 49.6%) was found among studies that compared alcoholics with ALD with healthy controls. In sensitivity analysis, the exclusion of individual studies or studies showing allele frequencies not in HWE did not change the results. The recessive contrast for the A allele (AA genotype vs. GA and GG genotypes) was not performed because of the low number of subjects with the AA genotype. The risk of alcoholic hepatitis was not evaluated, for the same reason as given above.
TNFA À238G>A and À308G>A polymorphisms and alcoholism
The meta-analyses for the associations of the TNFA À238G>A and À308G>A polymorphisms with alcoholism did not show any significant relation (Figure 3 ). Sensitivity analyses did not change the results. Significant heterogeneity (Q statistic P ¼ 0.03; I 2 ¼ 56.7%) was found among studies that compared the distributions of the À308G>A polymorphism between alcoholics and healthy controls. The recessive contrast for the A allele in both allelic variants was not performed because of the low number of subjects with the AA genotype.
DISCUSSION
This work represents a comprehensive and systematic evaluation of the risk of ALD or alcoholism related to possession of the A allele of both the À238G>A and À308G>A polymorphisms of the TNFA gene. Regarding the À238G>A polymorphism, meta-analysis carried out under a random-effects model showed a significant association between possession of the A allele of this polymorphism and the risk of alcoholic liver cirrhosis. This reflects the fact that most studies in this field (8 out of 10) have found a higher frequency of A allele carriers among patients with ALD when they are compared with healthy controls or alcoholics without ALD; the results reached statistical significance in 2 of these studies (14, 15) . However, nonsignificant results were found for comparison of alcoholics with ALD with both alcoholics without ALD (large heterogeneity was found between studies) and healthy controls.
Concerning the À308G>A polymorphism, our metaanalyses did not show an association of this allelic variant with either ALD or alcoholic liver cirrhosis. Nevertheless, the possibility of a relation between this polymorphism and acute alcoholic hepatitis that was previously suggested by Nguyen-Khac et al. (18) cannot be fully discounted by means of a meta-analysis, given that only 2 other studies (27, 28) have included patients with this phenotype. Despite this, we must highlight that the study by Nguyen-Khac et al. had a small sample size (58 patients vs. 47 controls) and that deviation from HWE was observed. These 2 conditions have been shown to increase the likelihood of not replicating a finding in a genetic association study-that is, of this result's being a false-positive one (33) .
The presence of conflicting results and heterogeneity among studies is quite common in genetic association studies and reflects the well-known potential weakness and biases of this type of research, such as genotyping error, phenotype misclassification, interaction with other confounding factors, population stratification, and selective reporting biases (33) (34) (35) . Regarding studies analyzing the relation of allelic variants with ALD, phenotype misclassification and the use of different definitions for cases and controls probably accounts for a significant part of the heterogeneity found. First, we may consider that different criteria are used for defining alcoholics with liver disease, with the inclusion of patients with definite cirrhosis, patients with probable cirrhosis (with the risk of misclassification), or patients with acute alcoholic hepatitis. Second, different definitions are also used for controls, and most studies include convenience samples as controls rather than consecutively or randomly selected controls. One of the main difficulties of integrating previous work in this field is precisely that, considering the 11 studies eligible for inclusion in our meta-analysis, 5 studies included a group of ''alcoholics without liver disease'' as a control group, whereas 6 studies included only ''healthy subjects'' as controls. Although the inclusion of alcoholics without ALD as controls is theoretically preferable, since it permits the study, in isolation, of the direct association between genetic polymorphisms and the risk of liver disease on a background of alcoholism (9) , this approach also has limitations. Thus, a percentage of alcoholics with ALD may inadvertently be misclassified as patients without liver disease if liver biopsy is not performed; this technique was used in only 1 study included in our analysis. In an attempt to diminish the potential bias caused by these different definitions, we performed separate metaanalyses for each group of controls, as well as a metaanalysis for patients with alcoholic liver cirrhosis as cases. This approach, however, has the limitation of a lower sample size for each meta-analysis.
Apart from this source of heterogeneity, true genetic diversity across different samples (due to racial differences or differences in gene-environment interactions) or occult population stratification may partly explain the diverse results found. For instance, although all of the included studies were performed in European Caucasians, genetic differences cannot be excluded, and this may justify the higher frequency of GA and AA genotypes in patients with ALD found in our sample (15) when compared with other samples from different studies. Concerning publication and selective reporting bias, there is no way to be certain about their presence, and we must also keep in mind that the exclusion of unpublished studies may always affect the validity of the analysis. Finally, although we must consider that lack of reporting should not be assumed to imply poor study quality, most investigators did not report blinding or did not use matching or adjustment for potential confounders (such as age or sex). Although assessment of the quality of each study and its influence on the final results is difficult, all of these potential biases may lead to lack of replication and/or heterogeneity and preclude the drawing of definite conclusions.
Meta-analysis provides a robust tool with which to analyze discrepant results and explore the heterogeneity between studies (36) . In this case, either due to true genetic heterogeneity or due to biases, we must admit that the hypothesized association between these polymorphisms and ALD cannot be clearly refuted or confirmed in light of the present data. Given that previous studies have consistently shown that patients with cirrhosis or advanced liver disease have elevated TNF-a levels when compared with alcoholics without ALD (10) (11) (12) and therefore an association between these polymorphisms and ALD would be biologically plausible, further work is required to determine whether this relation exists.
